[Multiple sclerosis--immunopathogenesis, traditional therapeutic strategy and suggested combined immunotherapy].
D000477:Alkylating Agents / Q000008:administration & dosage; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000628:therapy*; D004322:Drainage; D004359:Drug Therapy, Combination; D005231:Fatty Acids, Unsaturated / Q000627:therapeutic use; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007167:Immunotherapy / Q000379:methods*; D009103:Multiple Sclerosis / Q000209:etiology / Q000628:therapy*; D013897:Thoracic Duct
D000477:Alkylating Agents; D000961:Antilymphocyte Serum; D005231:Fatty Acids, Unsaturated; D007166:Immunosuppressive Agents
Stwardnienie rozsiane--immunopatogeneza, dotychczasowa strategia terapeutyczna oraz projekt skojarzonej terapii immunotropowej.